S5 show that GLP-1RA were associated with lower risks as compared with placebo (16% lower risk), DPP-4 inhibitors (15% lower risk) and SGLT-2 inhibitors (10% lower risk), but the difference was statistically significant as compared with placebo only
It is the latest step in a concerted push by the pharmaceutical industry to develop an oral treatment to rival the results of the GLP-1 injectable medications, which have surged in popularity
They will help you create a nutritious eating plan that you can enjoy, teach you about portion control, and provide strategies for navigating social events and emotional eating
Clinical studies show that individuals who combine GLP-1 medications with a balanced diet and regular exercise experience better outcomes than with medication aloneincluding improved weight management, better blood sugar control, and enhanced overall well-being
However, symptoms may temporarily worsen following dose increases
What Happens After GLP-1 Weight Loss